Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors

BACKGROUND: Motesanib is a potent inhibitor of VEGFR1, 2 and 3, PDGFR and Kit receptors. In this report we examine the interaction between motesanib and radiation in vitro and in head and neck squamous cell carcinoma (HNSCC) xenograft models. EXPERIMENTAL DESIGN: In vitro assays were performed to as...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kruser, Tim J., Wheeler, Deric L., Armstrong, Eric A., Iida, Mari, Kozak, Kevin R., van der Kogel, Albert J., Bussink, Johan, Coxon, Angela, Polverino, Anthony, Harari, Paul M.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216115/
https://ncbi.nlm.nih.gov/pubmed/20507929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-3385
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires